193 related articles for article (PubMed ID: 25450774)
21. A Functional Analysis of the Cyclophilin Repertoire in the Protozoan Parasite
Perrone AE; Milduberger N; Fuchs AG; Bustos PL; Bua J
Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30384485
[No Abstract] [Full Text] [Related]
22. Differential gene expression in benznidazole-resistant Trypanosoma cruzi parasites.
Villarreal D; Nirdé P; Hide M; Barnabé C; Tibayrenc M
Antimicrob Agents Chemother; 2005 Jul; 49(7):2701-9. PubMed ID: 15980339
[TBL] [Abstract][Full Text] [Related]
23. Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations.
Lima DA; Gonçalves LO; Reis-Cunha JL; Guimarães PAS; Ruiz JC; Liarte DB; Murta SMF
Parasit Vectors; 2023 May; 16(1):167. PubMed ID: 37217925
[TBL] [Abstract][Full Text] [Related]
24. Drug-resistant epimastigotes of Trypanosoma cruzi and persistence of this phenotype after differentiation into amastigotes.
Nirdé P; Larroque C; Barnabé C
C R Acad Sci III; 1995 Dec; 318(12):1239-44. PubMed ID: 8745639
[TBL] [Abstract][Full Text] [Related]
25. Changes of RAPD profile of Trypanosoma cruzi II with Canova and Benznidazole.
Aleixo DL; Ferraz FN; de Melo CS; Gomes ML; Toledo MJ; Kaneshima EN; Bersani-Amado CA; Araújo SM
Homeopathy; 2008 Apr; 97(2):59-64. PubMed ID: 18439965
[TBL] [Abstract][Full Text] [Related]
26. Cyclophilin 19 secreted in the host cell cytosol by Trypanosoma cruzi promotes ROS production required for parasite growth.
Dos Santos GP; Abukawa FM; Souza-Melo N; Alcântara LM; Bittencourt-Cunha P; Moraes CB; Jha BK; McGwire BS; Moretti NS; Schenkman S
Cell Microbiol; 2021 Apr; 23(4):e13295. PubMed ID: 33222354
[TBL] [Abstract][Full Text] [Related]
27. Gene expression study using real-time PCR identifies an NTR gene as a major marker of resistance to benzonidazole in Trypanosoma cruzi.
Mejía-Jaramillo AM; Fernández GJ; Palacio L; Triana-Chávez O
Parasit Vectors; 2011 Sep; 4():169. PubMed ID: 21892937
[TBL] [Abstract][Full Text] [Related]
28. [Trypanosoma cruzi strains resistant to benznidazole occurring in Colombia].
Mejía-Jaramillo AM; Fernández GJ; Montilla M; Nicholls RS; Triana-Chávez O
Biomedica; 2012 Jun; 32(2):196-205. PubMed ID: 23242293
[TBL] [Abstract][Full Text] [Related]
29. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
Fernández MC; González Cappa SM; Solana ME
Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole.
Campos MC; Phelan J; Francisco AF; Taylor MC; Lewis MD; Pain A; Clark TG; Kelly JM
Sci Rep; 2017 Oct; 7(1):14407. PubMed ID: 29089615
[TBL] [Abstract][Full Text] [Related]
31.
Perrone AE; Pinillo M; Rial MS; Fernández M; Milduberger N; González C; Bustos PL; Fichera LE; Laucella SA; Albareda MC; Bua J
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569250
[TBL] [Abstract][Full Text] [Related]
32. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole.
Murta SM; Romanha AJ
Parasitology; 1998 Feb; 116 ( Pt 2)():165-71. PubMed ID: 9509026
[TBL] [Abstract][Full Text] [Related]
33. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of eukaryotic initiation factor 5A (eIF5A) affects susceptibility to benznidazole in Trypanosoma cruzi populations.
Moreira DS; Duarte AP; Pais FSM; Silva-Pereira RAD; Romanha AJ; Schenkman S; Murta SMF
Mem Inst Oswaldo Cruz; 2018 Jul; 113(9):e180162. PubMed ID: 30066751
[TBL] [Abstract][Full Text] [Related]
35. Mapping benznidazole resistance in trypanosomatids and exploring evolutionary histories of nitroreductases and ABCG transporter protein sequences.
Petravicius PO; Costa-Martins AG; Silva MN; Reis-Cunha JL; Bartholomeu DC; Teixeira MMG; Zingales B
Acta Trop; 2019 Dec; 200():105161. PubMed ID: 31494121
[TBL] [Abstract][Full Text] [Related]
36. Trypanosoma rangeli and Trypanosoma cruzi: molecular characterization of genes encoding putative calcium-binding proteins, highly conserved in trypanosomatids.
Porcel BM; Bontempi EJ; Henriksson J; Rydåker M; Aslund L; Segura EL; Pettersson U; Ruiz AM
Exp Parasitol; 1996 Dec; 84(3):387-99. PubMed ID: 8948328
[TBL] [Abstract][Full Text] [Related]
37. Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease.
Villarreal D; Barnabé C; Sereno D; Tibayrenc M
Exp Parasitol; 2004; 108(1-2):24-31. PubMed ID: 15491545
[TBL] [Abstract][Full Text] [Related]
38. Acute Chagas outbreaks: molecular and biological features of Trypanosoma cruzi isolates, and clinical aspects of acute cases in Santander, Colombia.
Díaz ML; Leal S; Mantilla JC; Molina-Berríos A; López-Muñoz R; Solari A; Escobar P; González Rugeles CI
Parasit Vectors; 2015 Nov; 8():608. PubMed ID: 26612724
[TBL] [Abstract][Full Text] [Related]
39. In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon.
Teston AP; Monteiro WM; Reis D; Bossolani GD; Gomes ML; de Araújo SM; Bahia MT; Barbosa MG; Toledo MJ
Trop Med Int Health; 2013 Jan; 18(1):85-95. PubMed ID: 23130989
[TBL] [Abstract][Full Text] [Related]
40. Benznidazole-resistance in Trypanosoma cruzi is a readily acquired trait that can arise independently in a single population.
Mejia AM; Hall BS; Taylor MC; Gómez-Palacio A; Wilkinson SR; Triana-Chávez O; Kelly JM
J Infect Dis; 2012 Jul; 206(2):220-8. PubMed ID: 22551809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
